Research Signal – Source date 2024-01-01
A structured calorie-restriction program changed one group of blood proteins associated with cellular senescence, but researchers detected no statistically significant intervention-related changes in the expression of the senescence-related genes measured inside circulating T cells. That is the central result of an ancillary investigation nested within an 18-week randomized controlled trial of 58 adults aged 50–70 with obesity and prediabetes.
The finding is scientifically useful because it separates two kinds of evidence that are easy to blend together. A lower concentration of selected proteins in plasma is not the same as evidence that senescent cells were removed. Nor does the result show that aging was reversed. It suggests that a substantial, structured weight-loss intervention can alter part of the circulating environment associated with senescence without a statistically significant change in the measured T-cell gene expression.
A controlled program produced a large weight difference
The study compared 31 people assigned to calorie restriction with 27 assigned to a control condition focused on weight stability. The calorie-restriction group followed a high-protein program targeting a 10% reduction from baseline weight. It used meal-replacement products, planned meals and snacks, daily food logs, and biweekly behavioral counseling led by a registered dietitian. Participants were encouraged to keep their usual level of physical activity.
The control group attended behavioral education sessions and was monitored to keep weight within about 5% of baseline. This was a comparison with a much smaller change in body weight, not a test of one ordinary diet against another freely chosen eating pattern.
After 18 weeks, the calorie-restriction group lost an average of 10.8 kilograms, or about 11.3% of body weight. The control group gained an average of 0.5 kilograms. The intervention was also accompanied by improvements in HbA1c, waist circumference, fasting insulin, insulin resistance measured by HOMA-IR, and diastolic blood pressure. Fasting glucose did not show a between-group difference.
Those results establish the trial’s main physical and metabolic contrast. They do not, by themselves, identify which biological changes produced the improvements. The biomarker investigation asked whether a pattern linked to cellular senescence changed alongside the intervention.
Two blood compartments answered different questions
Cellular senescence is a state in which a cell enters a lasting nondividing state. Senescent cells can release a mixture of signaling substances known as the senescence-associated secretory phenotype, or SASP. The mixture can include inflammatory signals, growth modulators, and enzymes involved in tissue remodeling. In this study, the researchers examined two related but nonidentical readouts.
First, they isolated CD3-positive T cells from blood and measured expression of selected genes. The genes included p16 and p21, which are used as markers connected with cellular senescence, along with BCL2L1 and BAK1, which are related to apoptosis and cell survival. This test asks about gene activity inside a particular population of circulating immune cells.
Second, the researchers measured 25 proteins in plasma, the liquid portion of blood. These proteins are substances circulating outside the cells that released them, and their levels can reflect contributions from multiple tissues. A plasma measurement therefore cannot be treated as a direct count of senescent cells in the body.
After adjustment for age, sex and race, the researchers found no statistically significant intervention-related change in T-cell expression of p16, p21, BCL2L1 or BAK1. They also detected no statistically significant association between changes in these gene-expression measures and changes in body weight. These findings do not establish that the intervention had no effect on the measured markers.
The plasma results were more selective. The intervention did not make every measured protein move in the same direction, and the strongest result came from combining proteins into broader patterns rather than treating the panel as one universal aging score.
One protein pattern moved with the intervention
To handle the 25 plasma measurements, the researchers used exploratory factor analysis. In plain terms, they looked for groups of proteins whose baseline patterns tended to vary together, then built three composite SASP Factor scores. A composite is a summary of its included measurements; it is not a new molecule and it does not mean that every component changed in the same way.
The clearest intervention result involved SASP Factor 2. It contained eight proteins: TNFRI, TNFRII, uPAR, MMP1, GDF15, OPN, Fas and MPO. Factor 2 was reduced in the calorie-restriction group relative to control, with an intervention comparison of p = .046. The change in this factor was also associated with the amount of weight lost. In the detailed analysis, the unadjusted relationship had an R² of 0.13 and p = .01.
An association of this size describes shared variation, not a proved chain of cause and effect. People with larger weight changes tended to show larger changes in Factor 2, but the analysis does not establish that the protein shift caused the metabolic improvements, or that the weight loss acted through this factor.
The composite approach also matters for interpretation. The authors note that individual proteins within another grouping, Factor 1, could move in opposing directions. Activin A and PAI-1 showed some of the largest decreases in the calorie-restriction group, while MMP9 increased. Those movements could partially cancel out when averaged into a composite. A stable or modest factor score can therefore conceal meaningful changes in individual constituents, just as a lower factor score does not mean that every protein in it fell.
The result points to activity, not proven cell removal
The authors describe the pattern as potentially senomorphic, meaning that it may reflect a change in senescence-associated activity or signaling, rather than a senolytic effect that eliminates senescent cells. The wording is appropriately cautious. Factor 2 came from circulating proteins, while the T-cell gene-expression measurements showed no statistically significant intervention-related changes.
That combination leaves several biological possibilities open. The intervention may have changed signals released by cells without reducing their abundance. Effects in tissues contributing to plasma proteins may not be captured by the measured T-cell markers. Or the measured blood proteins may reflect broader effects of weight loss, metabolism or inflammation without providing a complete readout of senescent-cell burden.
The study cannot resolve those possibilities because senescence is not one uniform process distributed equally across the body. The absence of statistically significant intervention-related changes in T-cell expression of p16 and p21 does not settle what happened in adipose tissue, liver, pancreatic beta cells or other tissues. Conversely, the lower plasma composite does not establish that senescent cells disappeared from those locations.
Several limits make the uncertainty specific rather than merely formal. This was a preliminary ancillary investigation with 58 participants, and some T-cell samples were lost because isolating the cells and measuring their expression was technically challenging. The population was limited to adults aged 50–70 with obesity and prediabetes, and the intervention combined a calorie deficit with a structured high-protein program and counseling. The three protein factors were exploratory summaries. Finally, 18 weeks is long enough to observe a substantial weight change but too brief to show whether the blood pattern persists during later weight maintenance or whether it reflects immediate calorie restriction.
What this could mean for metabolic health
The contemporaneous possibility raised by this trial is that a structured weight-loss intervention could reduce some harmful senescence-associated signaling in people with obesity and prediabetes, creating one plausible biological route toward better metabolic health. That route remains conditional: the blood changes would need to correspond to relevant tissue processes, persist beyond active restriction, and contribute to health improvements rather than merely accompany them.
If those links are established, blood-based protein patterns could become useful for tracking how weight-loss interventions affect biology that is difficult to measure directly in tissues. The current study is an early step toward that capability, not evidence that the program prevents diabetes, slows aging or extends life. Its strongest contribution is narrower and more practical: it shows that a circulating senescence-associated protein composite can change even when measured T-cell senescence markers show no statistically significant intervention-related change, giving future studies a sharper question to test.
Key Sources
- Primary source: Caloric Restriction Intervention Alters Specific Circulating Biomarkers of the Senescence-Associated Secretome in Middle-Aged and Older Adults With Obesity and Prediabetes in an 18-Week Randomized Controlled Trial.
DOI or Journal Page · Clinical Trial · 2024-01-01
Keep exploring